In This Article:
The German market has shown resilience, with the DAX index eking out a modest gain amid cautious investor sentiment following the U.S. Federal Reserve's recent rate cut. In this environment, growth companies with high insider ownership can offer unique opportunities, as they often align management interests with those of shareholders. When evaluating stocks in such a climate, it's important to consider factors like strong revenue growth and significant insider investment, which can signal confidence in the company's future prospects.
Top 10 Growth Companies With High Insider Ownership In Germany
| Name | Insider Ownership | Earnings Growth |
| pferdewetten.de (XTRA:EMH) | 26.8% | 98.3% |
| Stemmer Imaging (XTRA:S9I) | 25.2% | 23.2% |
| Deutsche Beteiligungs (XTRA:DBAN) | 39.5% | 54.1% |
| Exasol (XTRA:EXL) | 25.3% | 117.1% |
| adidas (XTRA:ADS) | 16.6% | 42.1% |
| Alelion Energy Systems (DB:2FZ) | 37.4% | 106.6% |
| Beyond Frames Entertainment (DB:8WP) | 10.8% | 112.2% |
| R. STAHL (XTRA:RSL2) | 37.9% | 59.3% |
| Redcare Pharmacy (XTRA:RDC) | 17.4% | 51.8% |
| Your Family Entertainment (DB:RTV) | 17.3% | 116.8% |
Let's explore several standout options from the results in the screener.
Hypoport
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Hypoport SE develops and markets technology platforms for the financial services, property, and insurance industries in Germany, with a market cap of €1.84 billion.
Operations: The company's revenue segments include €157.97 million from the Credit Platform and €66.89 million from the Insurance Platform, with a Segment Adjustment of €175.87 million.
Insider Ownership: 35%
Earnings Growth Forecast: 35% p.a.
Hypoport SE, recently added to the MDAX Index, is forecasted to grow its revenue at 12.6% per year, outpacing the German market's 5.5%. The company's earnings are expected to increase significantly by 35% annually over the next three years. Despite becoming profitable this year and showing strong growth potential, Hypoport's share price has been highly volatile recently and its Return on Equity is projected to be low at 10% in three years.
-
Unlock comprehensive insights into our analysis of Hypoport stock in this growth report.
-
Our expertly prepared valuation report Hypoport implies its share price may be too high.
Redcare Pharmacy
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Redcare Pharmacy NV operates an online pharmacy business across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €2.50 billion.
Operations: Redcare Pharmacy NV generates revenue from two main segments: €1.74 billion from the DACH region and €391 million from its International operations.